{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T05:07:10Z","timestamp":1764997630577,"version":"3.40.5"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.euroneuro.2024.07.015","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T20:08:22Z","timestamp":1725307702000},"page":"15-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Association between exposure to antidepressants and stimulants and age at onset of mania or psychosis: A retrospective population-based cohort study"],"prefix":"10.1016","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2513-2718","authenticated-orcid":false,"given":"Alessandro","family":"Miola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1272-5503","authenticated-orcid":false,"given":"Mete","family":"Ercis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7566-7334","authenticated-orcid":false,"given":"Vanessa K.","family":"Pazdernik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Fuentes Salgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3983-1322","authenticated-orcid":false,"given":"Javier","family":"Ortiz-Orendain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9825-8792","authenticated-orcid":false,"given":"Manuel","family":"Gardea-Res\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peggy M.","family":"Gruhlke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1014-3393","authenticated-orcid":false,"given":"Ian","family":"Michel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Michael","family":"Bostwick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alastair J","family":"McKean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3630-4773","authenticated-orcid":false,"given":"Jennifer L.","family":"Vande Voort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9455-5896","authenticated-orcid":false,"given":"Aysegul","family":"Ozerdem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Frye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2024.07.015_bib0001","first-page":"153","article-title":"Sigma-1 receptor agonists and their clinical implications in neuropsychiatric disorders","author":"Albayrak","year":"2017","journal-title":"Sigma Receptors: Their Role in Disease and as Therapeutic Targets"},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0002","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1176\/ajp.152.8.1130","article-title":"Antidepressant-induced mania and cycle acceleration: a controversy revisited","volume":"152","author":"Altshuler","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0003","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1038\/sj.npp.1301164","article-title":"Stimulants: therapeutic actions in ADHD","volume":"31","author":"Arnsten","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0004","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.schres.2007.10.005","article-title":"Mortality in schizophrenia and schizoaffective disorder: an Olmsted County, Minnesota cohort: 1950-2005","volume":"98","author":"Capasso","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0005","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/10445460050167287","article-title":"Stimulant treatment in young boys with symptoms suggesting childhood mania: a report from a longitudinal study","volume":"10","author":"Carlson","year":"2000","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0006","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/cap.2009.0036","article-title":"Psychotropic medication exposure and age at onset of bipolar disorder in offspring of parents with bipolar disorder","volume":"20","author":"Chang","year":"2010","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0007","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1521\/psyc.66.4.317.25437","article-title":"Antidepressant exposure in bipolar children","volume":"66","author":"Cicero","year":"2003","journal-title":"Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0008","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.eurpsy.2013.06.004","article-title":"Association between attention-deficit hyperactivity disorder in childhood and schizophrenia later in adulthood","volume":"29","author":"Dalsgaard","year":"2014","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0009","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.euroneuro.2023.11.006","article-title":"Clinical features in co-occuring obsessive-compulsive disorder and bipolar disorder: a systematic review and meta-analysis","volume":"80","author":"De Prisco","year":"2024","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.euroneuro.2023.10.002","article-title":"The never-ending problem: sample size matters","volume":"79","author":"De Prisco","year":"2024","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0011","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1089\/104454603322163899","article-title":"Rates and predictors of developing a manic or hypomanic episode 1 to 2 years following a first hospitalization for major depression with psychotic features","volume":"13","author":"DelBello","year":"2003","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0012","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1034\/j.1399-5618.2001.030201.x","article-title":"Prior stimulant treatment in adolescents with bipolar disorder: association with age at onset","volume":"3","author":"DelBello","year":"2001","journal-title":"Bipolar. Disord."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0013","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jad.2008.03.025","article-title":"Antidepressant-associated chronic irritable dysphoria (ACID) in STEP-BD patients","volume":"111","author":"El-Mallakh","year":"2008","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0014","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320970325","article-title":"May antidepressant drugs worsen the conditions they are supposed to treat? The clinical foundations of the oppositional model of tolerance","volume":"10","author":"Fava","year":"2020","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0015","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.pnpbp.2007.08.025","article-title":"The amphetamine-induced sensitized state as a model of schizophrenia","volume":"31","author":"Featherstone","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0016","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.euroneuro.2022.08.001","article-title":"Ethical considerations for precision psychiatry: a roadmap for research and clinical practice","volume":"63","author":"Fusar-Poli","year":"2022","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0017","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/104454603322163844","article-title":"Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial","volume":"13","author":"Galanter","year":"2003","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0018","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/JCP.0000000000001552","article-title":"Prescription stimulants and the risk of psychosis: a systematic review of observational studies","volume":"42","author":"Gallagher","year":"2022","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0019","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/s41380-022-01888-x","article-title":"Antidepressants that increase mitochondrial energetics may elevate risk of treatment-emergent mania","volume":"28","author":"Gardea-Resendez","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1241071","article-title":"Racial differences in pathways to care preceding first episode mania or psychosis: a historical cohort prodromal study","volume":"14","author":"Gardea-Resendez","year":"2023","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0021","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/11591660-000000000-00000","article-title":"Antidepressants and psychostimulants in pediatric populations: is there an association with mania?","volume":"13","author":"Goldsmith","year":"2011","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J. Biomed. Inform."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0023","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2174\/187152709789824633","article-title":"Can the sigma-1 receptor agonist fluvoxamine prevent schizophrenia?","volume":"8","author":"Hashimoto","year":"2009","journal-title":"CNS. Neurol. Disord. Drug Targets."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0024","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1517\/14728222.2011.560837","article-title":"Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders","volume":"15","author":"Hayashi","year":"2011","journal-title":"Expert. Opin. Ther. Targets."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0025","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S2215-0366(19)30189-0","article-title":"Methylphenidate and the risk of psychosis in adolescents and young adults: a population-based cohort study","volume":"6","author":"Hollis","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0026","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/archgenpsychiatry.2012.169","article-title":"The nature of dopamine dysfunction in schizophrenia and what this means for treatment","volume":"69","author":"Howes","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0027","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/acps.13333","article-title":"Index depressive episode and antidepressant exposure were associated with illness characteristics of pediatric bipolar disorder","volume":"145","author":"Inal","year":"2022","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0028","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00787-018-01269-2","article-title":"Antidepressant prescription patterns and CNS polypharmacy with antidepressants among children, adolescents, and young adults: a population-based study in Sweden","volume":"28","author":"Lagerberg","year":"2019","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0029","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.schres.2007.09.027","article-title":"Age-specific familial risks of psychotic disorders and schizophrenia: a nation-wide epidemiological study from Sweden","volume":"97","author":"Li","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0030","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.schres.2013.03.019","article-title":"A systematic review of psychostimulant treatment of negative symptoms of schizophrenia: challenges and therapeutic opportunities","volume":"147","author":"Lindenmayer","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0031","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1001\/jamapsychiatry.2017.2432","article-title":"Efficacy and safety of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and placebo for common psychiatric disorders among children and adolescents: a systematic review and meta-analysis","volume":"74","author":"Locher","year":"2017","journal-title":"JAMa Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0032","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/schbul\/sbu119","article-title":"Risk of Schizophrenia Increases After All Child and Adolescent Psychiatric Disorders: a Nationwide Study","volume":"41","author":"Maibing","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0033","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archpedi.158.8.773","article-title":"Age effects on antidepressant-induced manic conversion","volume":"158","author":"Martin","year":"2004","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0034","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1399-5618.2006.00342.x","article-title":"Attention-deficit hyperactivity disorder \u2013 bipolar comorbidity in children and adolescents","volume":"8","author":"Masi","year":"2006","journal-title":"Bipolar. Disord."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0035","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.schres.2020.12.026","article-title":"Intervention strategies for ultra-high risk for psychosis: progress in delaying the onset and reducing the impact of first-episode psychosis","volume":"228","author":"McGorry","year":"2021","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0036","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.euroneuro.2022.06.004","article-title":"Clinical and psychopathological correlates of duration of untreated illness (DUI) in affective spectrum disorders","volume":"61","author":"Menculini","year":"2022","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0037","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jpsychires.2023.06.021","article-title":"Prevalence and outcomes of rapid cycling bipolar disorder: mixed method systematic meta-review","volume":"164","author":"Miola","year":"2023","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0038","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40345-023-00318-3","article-title":"Factors associated with suicide attempts in the antecedent illness trajectory of bipolar disorder and schizophrenia","volume":"11","author":"Miola","year":"2023","journal-title":"Int. J. Bipolar. Disord."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0039","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40345-023-00300-z","article-title":"Characteristics of rapid cycling in 1261 bipolar disorder patients","volume":"11","author":"Miola","year":"2023","journal-title":"Int. J. Bipolar. Disord."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0040","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/acps.13497","article-title":"Factors associated with onset-age in major affective disorders","volume":"146","author":"Miola","year":"2022","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0041","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jpsychires.2015.09.012","article-title":"Prescription stimulant use is associated with earlier onset of psychosis","volume":"71","author":"Moran","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0042","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa1813751","article-title":"Psychosis with Methylphenidate or Amphetamine in Patients with ADHD","volume":"380","author":"Moran","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0043","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/JCP.0000000000001747","article-title":"Antidepressant-associated treatment emergent mania: a meta-analysis to guide risk modeling pharmacogenomic targets of potential clinical value","volume":"43","author":"Nu\u00f1ez","year":"2023","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0044","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jad.2023.07.106","article-title":"Antecedents to first episode psychosis and mania: comparing the initial prodromes of schizophrenia and bipolar disorder in a retrospective population cohort","volume":"340","author":"Ortiz-Orendain","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0045","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1399-5618.2007.00496.x","article-title":"Initiation of stimulant and antidepressant medication and clinical presentation in juvenile bipolar I disorder","volume":"10","author":"Pagano","year":"2008","journal-title":"Bipolar. Disord."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0046","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/WNF.0000000000000055","article-title":"Antidepressant-emergent mood switch in Korean adolescents with mood disorder","volume":"37","author":"Park","year":"2014","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0047","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206100","article-title":"Trends in use of prescription stimulants in the United States and Territories, 2006 to 2016","volume":"13","author":"Piper","year":"2018","journal-title":"PLoS. One"},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0048","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jad.2016.01.015","article-title":"Long-term risk of myocardial infarction and stroke in bipolar I disorder: a population-based Cohort Study","volume":"194","author":"Prieto","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0049","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1017\/S0033291722001428","article-title":"Do antidepressants prevent transition to psychosis in individuals at clinical high-risk (CHR-P)? Systematic review and meta-analysis","volume":"53","author":"Raballo","year":"2023","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0050","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0165-0327(02)00180-5","article-title":"Earlier onset of bipolar disorder in children by antidepressants or stimulants? An hypothesis","volume":"78","author":"Reichart","year":"2004","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0051","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0079-6123(08)00907-2","article-title":"Serotonin and dopamine interactions in psychosis prevention","volume":"172","author":"Richtand","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0052","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S2352-4642(18)30022-1","article-title":"The age of adolescence","volume":"2","author":"Sawyer","year":"2018","journal-title":"Lancet Child Adolesc. Health"},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0053","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.schres.2015.08.033","article-title":"Attention-deficit\/hyperactivity disorder, methylphenidate use and the risk of developing schizophrenia spectrum disorders: a nationwide population-based study in Taiwan","volume":"168","author":"Shyu","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0054","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S2215-0366(14)70379-7","article-title":"Accumulated environmental risk determining age at schizophrenia onset: a deep phenotyping-based study","volume":"1","author":"Stepniak","year":"2014","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0055","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1744-859X-10-26","article-title":"Fluvoxamine may prevent onset of psychosis: a case report of a patient at ultra-high risk of psychotic disorder","volume":"10","author":"Tadokoro","year":"2011","journal-title":"Ann. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0056","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1017\/S0954579406060512","article-title":"Controlled study of switching from attention-deficit\/hyperactivity disorder to a prepubertal and early adolescent bipolar I disorder phenotype during 6-year prospective follow-up: rate, risk, and predictors","volume":"18","author":"Tillman","year":"2006","journal-title":"Dev. Psychopathol."},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0057","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1097\/00004583-200312000-00016","article-title":"Ages of onset and rates of syndromal and subsyndromal comorbid DSM-IV diagnoses in a prepubertal and early adolescent bipolar disorder phenotype","volume":"42","author":"Tillman","year":"2003","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0058","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/jamapsychiatry.2023.3555","article-title":"Antidepressant Use and Risk of Manic Episodes in Children and Adolescents With Unipolar Depression","volume":"81","author":"Virtanen","year":"2024","journal-title":"JAMa Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.07.015_bib0059","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology, 2023. ATC classification index with DDDs."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X24001913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X24001913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:54:21Z","timestamp":1732668861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X24001913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":59,"alternative-id":["S0924977X24001913"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2024.07.015","relation":{},"ISSN":["0924-977X"],"issn-type":[{"type":"print","value":"0924-977X"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between exposure to antidepressants and stimulants and age at onset of mania or psychosis: A retrospective population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2024.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. and ECNP. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}